Inhaled mannitol in cystic fibrosis

Bibliography

• GEDDES D, BUSH A: Cystic fibrosis. In: Oxford Textbook of Medicine. Warrell DA, Cox TM, Firth JD (Eds), Oxford University Press, UK (2003) 4:1428-1438.
   Google Scholar
• BOUCHER RC: Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. Ann. Rev. Med. (2007) 58:157-170.
   PubMed Web of Science ®Google Scholar
• COLE P, WILSON R: Host–microbial interrelationships in respiratory infection. Chest (1989) 95:217S-221S.
   Web of Science ®Google Scholar
• ROBINSON M, EBERL S, TOMLINSON C et al.: Regional mucociliary clearance in patients with cystic fibrosis. J. Aerosol Med. (2000) 13:73-86.
   PubMedGoogle Scholar
• MATSUI H, VERGHESE MW, KESIMER M et al.: Reduced three-dimensional motility in dehydrated airway mucus prevents neutrophil capture and killing bacteria on airway epithelial surfaces. J. Immunol. (2005) 175:1090-1099.
   PubMed Web of Science ®Google Scholar
• WILLS PJ, COLE PJ: Mucolytic and mucokinetic therapy. Pulm. Pharmacol. (1996) 9:197-204.
   PubMedGoogle Scholar
• WILSON R, COLE PJ: The effect of bacterial products on ciliary function. Am. Rev. Respir. Dis. (1988) 138:S49-S53.
   PubMedGoogle Scholar
• WILLS PJ, GARCIA SUAREZ MG, RUTMAN A, WILSON R, COLE PJ: The ciliary transportability of sputum is slow on the mucus depleted bovine trachea. Am. J. Respir. Crit. Care Med. (1995) 151:1255-1258.
   PubMed Web of Science ®Google Scholar
• DAVISKAS E, ANDERSON SD: Hyperosmolar agents and clearance of mucus in the diseased airway. J. Aerosol Med. (2006) 19:100-109.
   PubMedGoogle Scholar
• KING M, RUBIN BK: Pharmacological approaches to discovery and development of new mucolytic agents. Adv. Drug Deliv. Rev. (2002) 54:1475-1490.
   PubMed Web of Science ®Google Scholar
• POOLE PJ, BLACK PN: Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review. Br. Med. J. (2001) 322:1271.
   PubMed Web of Science ®Google Scholar
• LIEBERMAN J, KURNICK NB: Influence of deoxyribonucleic acid content on the proteolysis of sputum and pus. Nature (1962) 196:988-990.
   PubMedGoogle Scholar
• LIEBERMAN J: Inhibition of protease activity in purulent sputum by DNA. J. Lab. Clin. Med. (1967) 70:595-605.
   PubMedGoogle Scholar
• PUCHELLE E, ZAHM JM, HAVEZ R: Biochemical and rheological data in sputum III. Relationship between the biochemical constituents and rheological properties of sputum. Bull. Physiopath. Respir. (1973) 9:237-256.
   PubMedGoogle Scholar
• PICOT R, DAS I, REID L: Pus, DNA and sputum viscosity. Thorax (1978) 33:235-242.
   PubMed Web of Science ®Google Scholar
• WINTERS SL, YEATES DB: Roles of hydration, sodium, and chloride in regulation of canine mucociliary transport system. J. Appl. Physiol. (1997) 83:1360-1369.
   PubMed Web of Science ®Google Scholar
• WILLS PJ, HALL RL, CHAN WM, COLE PJ: Sodium chloride increases the ciliary transportability of cystic fibrosis and bronchiectasis sputum on the mucus-depleted bovine trachea. J. Clin. Invest. (1997) 99:9-13.
   PubMed Web of Science ®Google Scholar
• INGELS KJ, KORTMANN MJ, NIJZIEL MR et al.: Factors influencing ciliary beat measurements. Rhinology (1991) 29:17-26.
   PubMedGoogle Scholar
• VAN DE DONK HJ, ZUIDEMA J, MERKUS FW: The influence of the pH and osmotic pressure upon tracheal ciliary beat frequency as determined with a new photo-electric registration device. Rhinology (1980) 18:93-104.
   PubMedGoogle Scholar
• DAVISKAS E, ANDERSON SD, EBERL S, CHAN H-K, BAUTOVICH G: Inhalation of dry powder mannitol improves clearance of mucus on patients with bronchiectasis. Am. J. Respir. Crit. Care Med. (1999) 159:1843-1848.
   PubMed Web of Science ®Google Scholar
• DAVISKAS E, ANDERSON SD, GOMES K et al.: Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis:effect on lung function, health status and sputum. Respirology (2005) 10:46-56.
   PubMed Web of Science ®Google Scholar
• DAVISKAS E, ANDERSON SD, YOUNG IH: Inhaled mannitol changes the sputum properties in asthmatics with mucus hypersecretion. Respirology (2007) (In Press).
   PubMedGoogle Scholar
• KISHIOKA C, OKAMOTO K, KIM J-S, RUBIN BK: Hyperosmolar solutions stimulate mucus secretion in the ferret trachea. Chest (2003) 124:306-313.
   PubMed Web of Science ®Google Scholar
• BRANNAN JD, GULLIKSSON M, ANDERSON SD et al.: Evidence of mast cell activation and leukotriene release after mannitol inhalation. Eur. Respir. J. (2003) 22:491-496.
   PubMed Web of Science ®Google Scholar
• PAVIA D, THOMSON ML, CLARKE SW: Enhanced clearance of secretions from the human lung after the administration of hypertonic saline aerosol. Am. Rev. Respir. Dis. (1978) 117:199-203.
   PubMed Web of Science ®Google Scholar
• ROBINSON M, REGNIS JA, BAILEY DL, KING M, BAUTOVICH GJ, BYE PTP: Effect of hypertonic saline, amiloride and cough on mucociliary clearance in patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. (1996) 153:1503-1509.
   PubMed Web of Science ®Google Scholar
• DAVISKAS E, ANDERSON SD, GONDS I et al.: Inhalation of hypertonic saline aerosol enhances mucociliary clearance in asthmatic and healthy subjects. Eur. Respir. J. (1996) 9:725-732.
   PubMed Web of Science ®Google Scholar
• ENG PA, MORTON J, DOUGLASS JA, RIEDLER J, WILSON J, ROBERTSON CF: Short term efficacy of ultrasonically nebulised hypertonic saline in cystic fibrosis. Pediatr. Pulmonol. (1996) 21:77-83.
   PubMed Web of Science ®Google Scholar
• DONALDSON SH, BENNETT WD, ZEMAN KL, KNOWLES MR, TARRAN R, BOUCHER RC: Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N. Engl. J. Med. (2006) 354:1848-1851.
   Google Scholar
• ELKINS MR, ROBINSON M, ROSE BR et al.: A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N. Engl. J. Med. (2006) 354:229-240.
   PubMed Web of Science ®Google Scholar
• ROBINSON M, DAVISKAS E, EBERL S et al.: The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study. Eur. Respir. J. (1999) 14:678-685.
   PubMed Web of Science ®Google Scholar
• DAVISKAS E, ANDERSON, SD, EBERL S, CHAN H-K, YOUNG IH: The 24-h effect of mannitol on the clearance of mucus in patients with bronchiectasis. Chest (2001) 119:414-421.
   PubMed Web of Science ®Google Scholar
• CHARLTON B, LASSIG A: Inhaled dry powder mannitol (Bronchitol) improves FEV1 in cystic fibrosis. Respirology (2006):A11.
   Google Scholar
• LAUBE BL, AUCI RM, SHIELDS DE et al.: Effect of rh DNase on airflow obstruction and mucociliary clearance in cystic fibrosis. Am. J. Respir. Crit. Care Med. (1996) 153:752-760.
   PubMed Web of Science ®Google Scholar
• WILLS PJ, WODEHOUSE T, CORKERY et al.: Short-term recombinant human DNase in bronchiectasis. Effect on clinical state and in vitro sputum transportability. Am. J. Respir. Crit. Care Med. (1996) 154:413-417.
   PubMed Web of Science ®Google Scholar
• O’DONNELL AE, BARKER AF, HOWITE JS, FICK RB: Treatment of idiopathic bronchiectasis with aerosolised recombinant human DNase I. Chest (1998) 113:1329-1334.
   PubMed Web of Science ®Google Scholar
• Pulmozyme disappoints in COPD. Scrip (1995) 2043:16.
   Google Scholar